Your browser doesn't support javascript.
loading
How Would You Manage This Patient With Clostridioides difficile Infection? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Kanjee, Zahir; Allegretti, Jessica R; Alonso, Carolyn D; Burns, Risa B.
Afiliação
  • Kanjee Z; Division of General Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (Z.K., R.B.B.).
  • Allegretti JR; Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (J.R.A.).
  • Alonso CD; Division of Infectious Diseases, Beth Israel Deaconess Medical Center; Harvard Medical School, Boston, Massachusetts (C.D.A.).
  • Burns RB; Division of General Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (Z.K., R.B.B.).
Ann Intern Med ; 176(8): 1101-1108, 2023 08.
Article em En | MEDLINE | ID: mdl-37549387
ABSTRACT
The Infectious Diseases Society of America/Society for Healthcare Epidemiology of America and the American College of Gastroenterology recently released updated guidelines on management of patients with Clostridioides difficile infection. Although these 2 guidelines generally agree, there are a few important differences in their advice to clinicians. In these rounds, 2 experts, an infectious diseases specialist and a gastroenterologist, discuss antibiotic treatment options for nonsevere disease, the role of fecal microbiota transplantation for fulminant disease, and the use of bezlotoxumab to prevent recurrence in the context of Ms. C, a 48-year-old woman with fulminant C difficile infection.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Infecções por Clostridium Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Infecções por Clostridium Idioma: En Ano de publicação: 2023 Tipo de documento: Article